Neurovascular Stents - Medical Devices Pipeline Assessment, 2017

2017-06-01
Price :
Published : Jun-2017
No. of Pages : 70
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Neurovascular Stents Overview 6
3 Products under Development 7
3.1 Neurovascular Stents - Pipeline Products by Stage of Development 7
3.2 Neurovascular Stents - Pipeline Products by Territory 8
3.3 Neurovascular Stents - Pipeline Products by Regulatory Path 9
3.4 Neurovascular Stents - Pipeline Products by Estimated Approval Date 10
3.5 Neurovascular Stents - Ongoing Clinical Trials 11
4 Neurovascular Stents - Pipeline Products under Development by Companies 12
4.1 Neurovascular Stents Companies - Pipeline Products by Stage of Development 12
4.2 Neurovascular Stents - Pipeline Products by Stage of Development 13
5 Neurovascular Stents Companies and Product Overview 14
5.1 Aneuclose LLC Company Overview 14
5.1.1 Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 Apeliotus Technologies Company Overview 15
5.2.1 Apeliotus Technologies Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 Codman & Shurtleff Inc Company Overview 16
5.3.1 Codman & Shurtleff Inc Pipeline Products & Ongoing Clinical Trials Overview 16
5.4 Cordis Corp Company Overview 18
5.4.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 18
5.5 Gaudi Vascular, Inc. Company Overview 19
5.5.1 Gaudi Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19
5.6 MicroPort Scientific Corp Company Overview 20
5.6.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 20
5.7 MicroVention, Inc. Company Overview 21
5.7.1 MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.8 Neurosigma Inc Company Overview 25
5.8.1 Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview 25
5.9 NSVascular, Inc. Company Overview 26
5.9.1 NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
5.10 Palmaz Scientific Inc Company Overview 27
5.10.1 Palmaz Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 27
5.11 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 28
5.11.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 28
5.12 University of California Los Angeles Company Overview 29
5.12.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 29
6 Neurovascular Stents- Recent Developments 30
6.1 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 30
6.2 Apr 23, 2017: Bard Announces First Quarter Results 31
6.3 Mar 30, 2017: MPSC Announces 2016 Annual Results 31
6.4 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 33
6.5 Feb 16, 2017: InspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016 36
6.6 Feb 14, 2017: MicroPort Receives CFDA Approval for APOLLO Intracranial Stent System in Large Sizes 37
6.7 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 38
6.8 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 38
6.9 Jan 26, 2017: Bard Announces Fourth Quarter Results 40
6.10 Dec 15, 2016: MicroPort NeuroTech Attends CINS 2016 40
6.11 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 41
6.12 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 44
6.13 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 44
6.14 Nov 14, 2016: InspireMD Reports Financial Results for the Third Quarter Ended September 30, 2016 45
6.15 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 47
6.16 Oct 25, 2016: Bard Announces Third Quarter Results 49
6.17 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 50
6.18 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 50
6.19 Sep 07, 2016: InspireMD Appoints Thomas Kester to Board of Directors 51
6.20 Aug 30, 2016: MPSC Announces 2016 Interim Results 52
6.21 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 53
6.22 Aug 09, 2016: InspireMD Reports Financial Results for the Second Quarter Ended June 30, 2016 56
6.23 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 58
6.24 Jul 26, 2016: Bard Announces Second Quarter Results 60
6.25 Jul 21, 2016: InspireMD Regains Compliance With NYSE MKT Listing Standards 61
6.26 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 61
6.27 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 61
6.28 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 62
6.29 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 62
6.30 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 63
7 Appendix 67
7.1 Methodology 67
7.2 About GlobalData 70
7.3 Contact Us 70
7.4 Disclaimer 70

1.1 List of Tables
Table 1: Neurovascular Stents - Pipeline Products by Stage of Development 7
Table 2: Neurovascular Stents - Pipeline Products by Territory 8
Table 3: Neurovascular Stents - Pipeline Products by Regulatory Path 9
Table 4: Neurovascular S

1.2 List of Figures
Figure 1: Neurovascular Stents - Pipeline Products by Stage of Development 7
Figure 2: Neurovascular Stents - Pipeline Products by Territory 8
Figure 3: Neurovascular Stents - Pipeline Products by Regulatory Path 9
Figure 4: Neurovascular Stents - Pipeline Products by Estimated Approval Date 10
Figure 5: Neurovascular Stents - Ongoing Clinical Trials 11
Filed in: Medical Device
Publisher : GlobalData